Fox Run Management, L.L.C. Cure Vac N.V. Transaction History

Fox Run Management, L.L.C.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$6.69 - $12.25 $112,532 - $206,057	-16,821 Reduced 53.78%	14,457 $150,000
Q1 2023 May 12, 2023	BUY	$6.38 - $12.5 $199,553 - $390,975	31,278 New	31,278 $218,000
Q3 2022 Nov 07, 2022	BUY	$7.48 - $15.24 $235,784 - $480,395	31,522 New	31,522 $248,000

12.2M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $716M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fox Run Management, L.L.C. with notifications on news.